Please Wait
Applying Filters...
Menu
Xls
Filters Filter
Cross PopUp
FILTER :

filter clear-filterReset all filters

01 1COUMADIN

02 1DEFINITY

03 1DEFINITY RT

04 4DOXERCALCIFEROL

05 1MACUGEN

06 1MYOZYME

07 1NUCALA

08 1REVCOVI

filter clear-filterReset all filters

filter clear-filterReset all filters

PharmaCompass

01

arrow
2024 ACI Convention
Not Confirmed
  • fda
  • EDQM
  • WHO-GMP

Virtual BoothSanofi is a pioneer in Diabetes Solutions, Human Vaccines, Innovative Drugs, Consumer Healthcare, and the new Genzyme.

ALGLUCOSIDASE ALFA

Drug : MYOZYME

Dosage Form : INJECTABLE; IV (INFUSION)

Application Number : 125141

Country : US

Patented : No

Sanofi Company Banner

02

arrow
2024 ACI Convention
Not Confirmed
arrow
2024 ACI Convention
Not Confirmed

DOXERCALCIFEROL

Drug : DOXERCALCIFEROL

Dosage Form : INJECTABLE; INJECTION

Application Number : 208975

Country : US

Patented : No

blank

03

arrow
2024 ACI Convention
Not Confirmed

04

arrow
2024 ACI Convention
Not Confirmed

05

arrow
2024 ACI Convention
Not Confirmed

06

arrow
2024 ACI Convention
Not Confirmed
arrow
2024 ACI Convention
Not Confirmed

DOXERCALCIFEROL

Drug : DOXERCALCIFEROL

Dosage Form : INJECTABLE; INJECTION

Application Number : 203929

Country : US

Patented : No

blank

07

arrow
2024 ACI Convention
Not Confirmed
arrow
2024 ACI Convention
Not Confirmed

MEPOLIZUMAB

Drug : NUCALA

Dosage Form : INJECTABLE; SUBCUTANEOUS LYOPHILIZED POWER

Application Number : 125526

Country : US

Patented : No

blank

08

arrow
2024 ACI Convention
Not Confirmed
arrow
2024 ACI Convention
Not Confirmed

DOXERCALCIFEROL

Drug : DOXERCALCIFEROL

Dosage Form : INJECTABLE; INJECTION

Application Number : 208614

Country : US

Patented : No

blank

09

arrow
2024 ACI Convention
Not Confirmed

10

arrow
2024 ACI Convention
Not Confirmed